Thermo Fisher Stock - Weekly sector review and peer comparison

Thermo Fisher Scientific stock ends the week after a muted stretch for life science tools, as investors weigh macro headwinds, funding trends and positioning against peers such as Danaher and Agilent.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 18:12 CET. Details in the imprint.

Thermo Fisher Scientific (US8835561023) ends this trading week as a bellwether for the life science tools sector. The stock reflects a cautious backdrop for laboratory equipment and diagnostics providers, with investors watching funding trends and peers across the Standard & Poor's 500 index.

How the shares ended the week

Thermo Fisher shares most recently closed at $465.98 on the New York Stock Exchange on 06/18/2026, according to consolidated price data. MarketBeat price data for TMO show a move of 0.93% for that regular session.

In after-hours trading on the same day, the shares changed hands at $462.03. This extended-session level was 0.85% below the official close, underlining a still cautious tone in the broader US health care complex.

Weekly view and sector backdrop

Across the week, life science tools and diagnostics stocks traded in a tight range, as investors monitored macroeconomic data and capital spending plans in biopharma and research. Peers such as Danaher and Agilent also showed muted moves in recent sessions.

Analysts continue to point to deferred instrument orders and pressured biotech funding as headwinds for the group, even as recurring consumables and service revenues offer some resilience. Against this backdrop, Thermo Fisher stock is often used as a sector proxy by institutional investors.

Where Thermo Fisher sits among peers

With a market capitalization around $175 billion at recent prices, Thermo Fisher is one of the largest health care equipment names in the Standard & Poor's 500 index. Its scale contrasts with smaller peers that tend to show more volatile trading patterns.

Valuation remains a key discussion point versus companies such as Danaher and Agilent, where investors compare growth in bioproduction, specialty diagnostics and analytical instruments. Public consensus screens continue to place Thermo Fisher in the upper range of the sector on earnings multiples.

The business behind the stock

Thermo Fisher generates revenue from laboratory instruments, reagents, consumables, specialty diagnostics and related services for pharmaceutical, biotechnology, academic and industrial customers worldwide. Its portfolio spans mass spectrometers, chromatography systems, genetic analyzers and a broad range of laboratory plastics and chemicals.

Where the stock trades today

The shares of Thermo Fisher Scientific (US8835561023) trade on the New York Stock Exchange at $465.98 as of 06/18/2026, 15:59 Eastern Time.

Key facts on Thermo Fisher stock

• Company: Thermo Fisher Scientific Inc.
• ISIN: US8835561023
• WKN: 857209
• Ticker: TMO
• Venue: NYSE
• Price (as of 06/18/2026, 15:59 Eastern Time): 465.98 USD
• Market cap: approximately 175,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care - Life Science Tools & Services
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.